Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study is to determine the safety and efficacy of stereotactic body radiotherapy (SBRT)
and treatment drug in patients with hepatocellular carcinoma.